Tracking the activation of Stat5 through the expression of an inducible reporter gene in a transgenic mouse line

Endocrinology

Volumn 152, Issue 5, 2011, Pages 1935-1947

  Bednorz, Nadja Lydia ^a   Brill, Boris ^a   Klein, Andreas ^b   Gäbel, Katrin ^a   Groner, Bernd ^a  

^a INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; LIPOPOLYSACCHARIDE; STAT5 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BREAST DEVELOPMENT; BREAST EPITHELIUM; CELL MATURATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DNA RESPONSIVE ELEMENT; EPITHELIUM CELL; FEMALE; GENE ACTIVITY; GENE EXPRESSION; GRANULOCYTE; HUMAN; HUMAN CELL; INVOLUTION; KIDNEY DEVELOPMENT; LACTATION; LIVER DEVELOPMENT; MACROPHAGE; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REPORTER GENE; THYMUS; TRANSGENIC MOUSE; UTERUS;

ANIMALS; BETA-GALACTOSIDASE; BLOTTING, WESTERN; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, REPORTER; HEK293 CELLS; HEP G2 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LAC OPERON; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PREGNANCY; RECOMBINANT FUSION PROTEINS; RESPONSE ELEMENTS; STAT5 TRANSCRIPTION FACTOR;

EID: 79955376825     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2011-0053     Document Type: Article

References (57)

1. Schindler C, Plumlee C 2008 Inteferons pen the JAK-STAT pathway. Semin Cell Dev Biol 19:311-318
2. Levy DE, Darnell Jr JE 2002 Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3:651-662 (Pubitemid 34987786)
3. Chen X, Vinkemeier U, Zhao Y, Jeruzalmi D, Darnell Jr JE, Kuriyan J 1998 Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell 93:827-839 (Pubitemid 28257588)
4. Azam M, Lee C, Strehlow I, Schindler C 1997 Functionally distinct isoforms of STAT5 are generated by protein processing. Immunity 6:691-701 (Pubitemid 27305732)
5. Moriggl R, Gouilleux-Gruart V, Jähne R, Berchtold S, Gartmann C, Liu X, Hennighausen L, Sotiropoulos A, Groner B, Gouilleux F 1996 Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype. Mol Cell Biol 16:5691-5700 (Pubitemid 26315089)
6. Schmitt-Ney M, Doppler W, Ball RK, Groner B 1991 β-Casein gene promoter activity is regulated by the hormone-mediated relief of transcriptional repression and a mammary-gland-specific nuclear factor. Mol Cell Biol 11:3745-3755 (Pubitemid 21895762)
7. Stocklin E, Wissler M, Gouilleux F, Groner B 1996 Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383:726-728 (Pubitemid 26360650)
8. Kato Y, Iwama A, Tadokoro Y, Shimoda K, Minoguchi M, Akira S, Tanaka M, Miyajima A, Kitamura T, Nakauchi H 2005 Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis. J Exp Med 202:169-179 (Pubitemid 41002919)
9. Wagner KU, Rui H 2008 Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression. J Mamm Gland Biol Neoplasia 13:93-103
10. Gouilleux F, Pallard C, Dusanter-Fourt I, Wakao H, Haldosen LA, Norstedt G, Levy D, Groner B 1995 Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity. EMBO J 14:2005-2013
11. Wakao H, Gouilleux F, Groner B 1994 Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J 13:2182-2191 (Pubitemid 24139732)
12. Kabotyanski EB, Rijnkels M, Freeman-Zadrowski C, Buser AC, Edwards DP, Rosen JM 2009 Lactogenic hormonal induction of long distance interactions between β-casein gene regulatory elements. J Biol Chem 284:22815-22824
13. Soldaini E, John S, Moro S, Bollenbacher J, Schindler U, Leonard WJ 2000 DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites. Mol Cell Biol 20:389-401 (Pubitemid 30002580)
14. Hoelbl A, Kovacic B, Kerenyi MA, Simma O, Warsch W, Cui Y, Beug H, Hennighausen L, Moriggl R, Sexl V 2006 Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation. Blood 107:4898-4906 (Pubitemid 43882643)
15. Wei L, Laurence A, O'Shea JJ 2008 New insights into the roles of Stat5a/b and Stat3 in T cell development and differentiation. Semin Cell Dev Biol 19:394-400
16. Cotarla I, Ren S, Zhang Y, Gehan E, Singh B, Furth PA 2004 Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers. Int J Cancer 108:665-671 (Pubitemid 38076397)
17. Moriggl R, Sexl V, Kenner L, Duntsch C, Stangl K, Gingras S, Hoffmeyer A, Bauer A, Piekorz R, Wang D, Bunting KD, Wagner EF, Sonneck K, Valent P, Ihle JN, Beug H 2005 Stat5 tetramer formation is associated with leukemogenesis. Cancer Cell 7:87-99 (Pubitemid 40126385)
18. Birkenkamp KU, Geugien M, Lemmink HH, Kruijer W, Vellenga E 2001 Regulation of constitutive STAT5 phosphorylation in acute myeloid leukemia blasts. Leukemia 15:1923-1931 (Pubitemid 33115000)
19. Gouilleux-Gruart V, Gouilleux F, Desaint C, Claisse JF, Capiod JC, Delobel J, Weber-Nordt R, Dusanter-Fourt I, Dreyfus F, Groner B, Prin L 1996 STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood 87:1692-1697 (Pubitemid 26068885)
20. Schmidt-Ullrich R, Memet S, Lilienbaum A, Feuillard J, Raphael M, Israel A 1996 NF-κB activity in transgenic mice: developmental regulation and tissue specificity. Development (Cambridge, England) 122:2117-2128
21. DasGupta R, Fuchs E 1999 Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation. Development (Cambridge, England) 126:4557-4568
22. Maretto S, Cordenonsi M, Dupont S, Braghetta P, Broccoli V, Hassan AB, Volpin D, Bressan GM, Piccolo S 2003 Mapping Wnt/β-catenin signaling during mouse development and in colorectal tumors. Proc Natl Acad Sci USA 100:3299-3304 (Pubitemid 36356577)
23. Davies PS, Dismuke AD, Powell AE, Carroll KH, Wong MH 2008 Wnt-reporter expression pattern in the mouse intestine during homeostasis. BMC Gastroenterol 8:57
24. Zangani M, Carlsen H, Kielland A, Os A, Hauglin H, Blomhoff R, Munthe LA, Bogen B 2009 Tracking early autoimmune disease by bioluminescent imaging of NF-κB activation reveals pathology in multiple organ systems. Am J Pathol 174:1358-1367
25. Bronson SK, Plaehn EG, Kluckman KD, Hagaman JR, Maeda N, Smithies O 1996 Single-copy transgenic mice with chosen-site integration. Proc Natl Acad Sci USA 93:9067-9072 (Pubitemid 26282019)
26. Grosveld F, van Assendelft GB, Greaves DR, Kollias G 1987 Position-independent, high-level expression of the human β-globin gene in transgenic mice. Cell 51:975-985
27. Fukumura D, Xavier R, Sugiura T, Chen Y, Park EC, Lu N, Selig M, Nielsen G, Taksir T, Jain RK, Seed B 1998 Tumor induction of VEGF promoter activity in stromal cells. Cell 94:715-725 (Pubitemid 28436004)
28. Fleenor DE, Kaufman RE 1993 Characterization of the DNase I hypersensitive site 3' of the human β globin gene domain. Blood 81:2781-2790 (Pubitemid 23147587)
29. Berchtold S, Moriggl R, Gouilleux F, Silvennoinen O, Beisenherz C, Pfitzner E, Wissler M, Stöcklin E, Groner B 1997 Cytokine receptorindependent, constitutively active variants of STAT5. J Biol Chem 272:30237-30243 (Pubitemid 27512227)
30. Yamaji D, Na R, Feuermann Y, Pechhold S, Chen W, Robinson GW, Hennighausen L 2009 Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A. Genes Dev 23:2382-2387
31. Philp JA, Burdon TG, Watson CJ 1996 Differential activation of STATs 3 and 5 during mammary gland development. FEBS Lett 396:77-80 (Pubitemid 26360284)
32. Schmitt-Ney M, Happ B, Hofer P, Hynes NE, Groner B 1992 Mammary gland-specific nuclear factor activity is positively regulated by lactogenic hormones and negatively by milk stasis. Mol Endocrinol (Baltimore, Md) 6:1988-1997 (Pubitemid 23021548)
33. Hennighausen L, Robinson GW 2008 Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B. Genes Dev 22:711-721 (Pubitemid 351439101)
34. Herrington J, Smit LS, Schwartz J, Carter-Su C 2000 The role of STAT proteins in growth hormone signaling. Oncogene 19:2585-2597 (Pubitemid 30339214)
35. Rabkin R, Sun DF, Chen Y, Tan J, Schaefer F 2005 Growthhormone resistance in uremia, a role for impaired JAK/STAT signaling. Pediatric Nephrology (Berlin, Germany) 20:313-318 (Pubitemid 40309935)
36. Schaefer F, Chen Y, Tsao T, Nouri P, Rabkin R 2001 Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia. J Clin Invest 108:467-475 (Pubitemid 32730793)
37. Dalrymple A, Jabbour HN 2000 Localization and signaling of the prolactin receptor in the uterus of the common marmoset monkey. J Clin Endocrinol Metab 85:1711-1718 (Pubitemid 32289523)
38. Spencer TE, Bazer FW 2002 Biology of progesterone action during pregnancy recognition and maintenance of pregnancy. Front Biosci 7: d1879-d1898
39. Klein A, Guhl E, Zollinger R, Tzeng YJ, Wessel R, Hummel M, Graessmann M, Graessmann A 2005 Gene expression profiling: cell cycle deregulation and aneuploidy do not cause breast cancer formation in WAP-SVT/t transgenic animals. J Mol Med (Berlin, Germany) 83:362-376 (Pubitemid 41201801)
40. Bunting KD 2007 STAT5 signaling in normal and pathologic hematopoiesis. Front Biosci 12:2807-2820
41. Dong F, Liu X, de Koning JP, Touw IP, Hennighausen L, Larner A, Grimley PM 1998 Stimulation of Stat5 by granulocyte colony-stimulating factor (G-CSF) is modulated by two distinct cytoplasmic regions of the G-CSF receptor. J Immunol 161:6503-6509 (Pubitemid 28562187)
42. Kimura A, Naka T, Muta T, Takeuchi O, Akira S, Kawase I, Kishimoto T 2005 Suppressor of cytokine signaling-1 selectively inhibits LPS-induced IL-6 production by regulating JAK-STAT. Proc Natl Acad Sci USA 102:17089-17094 (Pubitemid 41692688)
43. Yamaoka K, Otsuka T, Niiro H, Arinobu Y, Niho Y, Hamasaki N, Izuhara K 1998 Activation of STAT5 by lipopolysaccharide through granulocyte-macrophage colony-stimulating factor production in human monocytes. J Immunol 160:838-845 (Pubitemid 28049325)
44. Migone TS, Lin JX, Cereseto A, Mulloy JC, O'Shea JJ, Franchini G, Leonard WJ 1995 Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science (New York, NY) 269:79-81
45. Debierre-Grockiego F 2004 Anti-apoptotic role of STAT5 inhaematopoietic cells and in the pathogenesis of malignancies. Apoptosis 9:717-728 (Pubitemid 40941200)
46. Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, Hennighausen L 1997 Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev 11:179-186 (Pubitemid 27081895)
47. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ, Davey HW 1997 Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA 94:7239-7244 (Pubitemid 27345299)
48. Cui Y, Riedlinger G, Miyoshi K, Tang W, Li C, Deng CX, Robinson GW, Hennighausen L 2004 Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol Cell Biol 24:8037-8047 (Pubitemid 39167454)
49. Rosen JM, Wyszomierski SL, Hadsell D 1999 Regulation of milk protein gene expression. Annu Rev Nutr 19:407-436 (Pubitemid 29380611)
50. Pfitzner E, Jähne R, Wissler M, Stoecklin E, Groner B 1998 p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response. Mol Endocrinol (Baltimore, Md) 12:1582-1593 (Pubitemid 30663440)
51. Meier VS, Groner B 1994 The nuclear factor YY1 participates in repression of the β-casein gene promoter in mammary epithelial cells and is counteracted by mammary gland factor during lactogenic hormone induction. Mol Cell Biol 14:128-137
52. Harir N, Pecquet C, Kerenyi M, Sonneck K, Kovacic B, Nyga R, Brevet M, Dhennin I, Gouilleux-Gruart V, Beug H, Valent P, Lassoued K, Moriggl R, Gouilleux F 2007 Constitutive activation of Stat5 promotes its cytoplasmic localization and association with PI3-kinase in myeloid leukemias. Blood 109:1678-1686 (Pubitemid 46239602)
53. Sattler M, Griffin JD 2009 JAK2 gets histone H3 rolling. Cancer Cell 16:365-366
54. Dawson MA, Bannister AJ, Gottgens B, Foster SD, Bartke T, Green AR, Kouzarides T 2009 JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin. Nature 461:819-822
55. Chan CB, Liu X, Ensslin MA, Dillehay DL, Ormandy CJ, Sohn P, Serra R, Ye K 2010 PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. EMBO J 29:956-968
56. Gäbel K, Bednorz NL, Klemmt P, Vafaizadeh V, Borghouts C, Groner B 2010 Visualization of Stat3 and Stat5 transactivation activity with specific response element dependent reporter constructs integrated into lentiviral gene transfer vectors. Horm Mol Biol Clin Investig 1:127-137
57. Maurer-Gebhard M, Schmidt M, Azemar M, Altenschmidt U, Stöcklin E, Wels W, Groner B 1998 Systemic treatment with a recombinant erbB-2 receptor-specific tumor toxin efficiently reduces pulmonary metastases in mice injected with genetically modified carcinoma cells. Cancer Res 58:2661-2666 (Pubitemid 28275441)